Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Immunotherapy of melanoma: a critical review of current concepts and future strategies.

Riker AI, Radfar S, Liu S, Wang Y, Khong HT.

Expert Opin Biol Ther. 2007 Mar;7(3):345-58. Review.

PMID:
17309326
2.

Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.

Kalani AD, Jack A, Montenegro G, Degliuomini J, Wallack MK.

G Ital Dermatol Venereol. 2008 Feb;143(1):59-70. Review.

PMID:
18833052
3.

Biologic therapy of melanoma with cytokines and lymphocytes.

Bear HD, Hamad GG, Kostuchenko PJ.

Semin Surg Oncol. 1996 Nov-Dec;12(6):436-45. Review. Erratum in: Semin Surg Oncol 1997 Nov-Dec;13(6):465.

PMID:
8914208
4.

Biochemotherapy of melanoma.

Keilholz U.

Forum (Genova). 2003;13(2):158-65; quiz 189. Review.

PMID:
14732882
5.

Treatment for metastatic malignant melanoma: old drugs and new strategies.

Mouawad R, Sebert M, Michels J, Bloch J, Spano JP, Khayat D.

Crit Rev Oncol Hematol. 2010 Apr;74(1):27-39. doi: 10.1016/j.critrevonc.2009.08.005. Epub 2009 Sep 24. Review.

PMID:
19781957
6.

Melanoma vaccines.

Minev BR.

Semin Oncol. 2002 Oct;29(5):479-93. Review.

PMID:
12407513
7.

Cytokine-based therapy and biochemotherapy for advanced melanoma.

Atkins MB.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2353s-2358s. Review.

8.

The use of interferon-alpha in the treatment of cutaneous melanoma: a review.

Punt CJ.

Melanoma Res. 1998 Apr;8(2):95-104. Review.

PMID:
9610861
9.

Adjuvant immunotherapy for solid tumors: from promise to clinical application.

Mocellin S, Rossi CR, Lise M, Marincola FM.

Cancer Immunol Immunother. 2002 Dec;51(11-12):583-95. Epub 2002 Sep 17. Review.

PMID:
12439603
10.

Recent advances and hurdles in melanoma immunotherapy.

Jandus C, Speiser D, Romero P.

Pigment Cell Melanoma Res. 2009 Dec;22(6):711-23. doi: 10.1111/j.1755-148X.2009.00634.x. Epub 2009 Sep 7. Review.

PMID:
19735459
11.

Immunotherapy as part of a multidisciplinary approach to melanoma treatment.

Riker AI, Jove R, Daud AI.

Front Biosci. 2006 Jan 1;11:1-14. Review.

12.

Interleukin-2 for the treatment of melanoma.

Tarhini AA, Agarwala SS.

Curr Opin Investig Drugs. 2005 Dec;6(12):1234-9. Review.

PMID:
16370388
13.

Biochemotherapy for advanced melanoma.

Keilholz U, Gore ME.

Semin Oncol. 2002 Oct;29(5):456-61. Review.

PMID:
12407510
14.

Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine.

Nashan D, Müller ML, Grabbe S, Wustlich S, Enk A.

J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1305-18. Review.

PMID:
17958834
15.

Adjuvant therapy for malignant melanoma.

Stoutenburg JP, Schrope B, Kaufman HL.

Expert Rev Anticancer Ther. 2004 Oct;4(5):823-35. Review.

PMID:
15485316
16.

Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.

Khayat D, Coeffic D.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:238-47. Review. No abstract available.

PMID:
10895160
17.

Emerging therapies for melanoma.

Katipamula R, Markovic SN.

Expert Rev Anticancer Ther. 2008 Apr;8(4):553-60. doi: 10.1586/14737140.8.4.553. Review.

PMID:
18402522
18.

The treatment of melanoma with an emphasis on immunotherapeutic strategies.

Jack A, Boyes C, Aydin N, Alam K, Wallack M.

Surg Oncol. 2006 Jul;15(1):13-24. Epub 2006 Jul 11. Review.

PMID:
16815006
19.

Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.

Kim S, Haas GP, Hillman GG.

Cytokines Mol Ther. 1996 Mar;2(1):13-9. Review.

PMID:
9384685
20.

Perspectives in melanoma treatment with signal transduction.

La Porta CA.

Curr Med Chem Anticancer Agents. 2002 May;2(3):371-85. Review.

PMID:
12678738

Supplemental Content

Support Center